Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.38 -0.18 (-5.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Other Accumulated Expenses (2018 - 2026)

Updated

Bicycle Therapeutics (BCYC) reported Other Accumulated Expenses of $160,000 for Q2 2026, down 32.2% from $236,000 a year earlier and down 66.9% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Bicycle Therapeutics posted Other Accumulated Expenses of $136,000, down 54.2% from FY2024.

  • Other Accumulated Expenses has a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $297,000 in FY2024 (+15.6%), $257,000 in FY2023 (-82.5%), $1.47 million in FY2022 (+158.2%) and $570,000 in FY2021 (+174.0%).
  • Five-year quarterly Other Accumulated Expenses spans a low of $136,000 in Q4 2025 and a high of $1.47 million in Q4 2022.
  • Year over year, Other Accumulated Expenses gained in four of the last eight quarters, with an average decline of 2.0%.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q1 2022 (growth of 202.4%); the low point was Q4 2023 (a decline of 82.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $483,000 (Q1 2026), $136,000 (Q4 2025) and $204,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Bicycle Therapeutics 235.97 Mn 235.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 160,000.00
Mar 31, 2026 483,000.00
Dec 31, 2025 136,000.00
Sep 30, 2025 204,000.00
Jun 30, 2025 236,000.00
Mar 31, 2025 309,000.00
Dec 31, 2024 297,000.00
Sep 30, 2024 399,000.00
Jun 30, 2024 649,000.00
Mar 31, 2024 172,000.00
Dec 31, 2023 257,000.00
Sep 30, 2023 303,000.00
Jun 30, 2023 1.01 Mn
Mar 31, 2023 636,000.00
Dec 31, 2022 1.47 Mn
Sep 30, 2022 677,000.00
Jun 30, 2022 958,000.00
Mar 31, 2022 384,000.00
Dec 31, 2021 570,000.00
Sep 30, 2021 264,000.00
API Access

Bicycle Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCYC&period=max&api_key=YOUR_API_KEY